Research and Development

Showing 15 posts of 9599 posts found.

ralf_huss

German biotech Apceth appoints Prof. Ralf Huss

October 19, 2011 Research and Development appointment, research and development

Munich-based biotech Apceth has appointed Prof Ralf Huss to its management board. Prof Huss moves to the company from Roche, …
Lundbeck headquarters, Denmark

Lundbeck establishes research centre in China

October 18, 2011 Research and Development Brain disorders, CNS, China, Lundbeck, Shanghai, emerging markets

Lundbeck has set up a new research centre in China, joining a wave of pharma companies investing in the region. The …

EMA resources stretched by Mediator scandal

October 18, 2011 Research and Development, Sales and Marketing EMA, Mediator

The European Medicines Agency has been forced to use ‘considerable resources’ to deal with a flood of enquiries over Mediator …
Roche

Roche buys US firm Anadys for $230 million

October 17, 2011 Research and Development, Sales and Marketing Roche, hepatitis C

Roche has acquired US firm Anadys for $230 million, bolstering its infectious drugs pipeline. California-based Anadys develops oral, small molecule …

Quintiles opens new European headquarters in the UK

October 12, 2011 Research and Development Quintiles, research and development news

Pharmaceutical services company Quintiles has opened a new European headquarters in the UK. The Reading, Berkshire facility will house more …
India

India will scrutinise foreign investment in pharma

October 11, 2011 Manufacturing and Production, Research and Development, Sales and Marketing India, Indian pharmaceutical industry

The Indian government has decided not to put any restrictions on the level of foreign direct investment (FDI) in the …

Parexel to work with Singapore on clinical research training

October 11, 2011 Research and Development Asia, CRO, Parexel, Singapore, clinical research

Parexel and the National University of Singapore have launched a new academic course to train Asia’s scientist to work in …
merck_co_richard_clark

Merck & Co chairman Richard Clark retires

October 10, 2011 Research and Development, Sales and Marketing appointment, sales and marketing

Richard Clark will step down as chairman of Merck & Co on 1 December after leading the company for six …
Boehringer

Boehringer signs away HIV rights to focus on hep C

October 7, 2011 Research and Development Boehringer, Gilead, HIV, hepatitis C

Boehringer Ingelheim has signed a deal giving Gilead Sciences exclusive worldwide rights to a major part of its HIV portfolio. …

UK funding boost for early-stage research

October 7, 2011 Research and Development NIHR, UK science

The government has established a new research institute to aid public and private groups working on the early stages of …
European Parliament

EMA tightens conflict of interest rules

October 6, 2011 Research and Development, Sales and Marketing EMA

The European Medicines Agency is tightening up its conflict of interest rules with a new ‘experts database’. This will allow …

Call for open access to all clinical trial data

October 6, 2011 Research and Development Cochrane, clinical trials, clinical trials analysis

There should be free access to all clinical trials in order to end selective reporting, according to a leading not-for-profit …

Merck appoints new chief strategy officer

October 6, 2011 Manufacturing and Production, Research and Development, Sales and Marketing appointment, manufacturing and production, research and development, sales and marketing

Cuong Viet Do has joined Merck & Co as chief strategy officer, replacing Mervyn Turner who retired from the US …
Merck Serono

Merck KGaA signs MS and cancer research deal

October 5, 2011 Research and Development Merck KGaA

Merck KGaA has signed development deals with Japanese firm Ono Pharmaceutical Co around two investigational treatments, one for multiple sclerosis …

Blocking pain – a long-term mission for pharma research

October 5, 2011 Research and Development chronic pain, neuropathic pain, pain therapeutics

Pain is a common, yet complex, clinical problem and one which remains an area of unmet need. There are however, …
The Gateway to Local Adoption Series

Latest content